Loading...
Loading...
Browse all stories on DeepNewz
VisitIn which non-medical field will Neuralink's N1 implant achieve a milestone by end of 2025?
Gaming • 25%
Virtual Reality • 25%
Augmented Reality • 25%
Other • 25%
Neuralink announcements and tech news outlets
Neuralink's N1 Implant with 1,024 Electrodes Promises Thought-Controlled Interaction at 9.5 BPS for Paralysis Patients
Dec 16, 2024, 09:02 AM
Neuralink's N1 implant is being hailed as a groundbreaking technology that could revolutionize the way individuals with paralysis interact with the world. The coin-sized device integrates 1,024 electrodes across 64 ultra-thin threads, achieving a bandwidth of 9.5 Bits Per Second (BPS), which is approximately 50% of normal human capability. This technology allows users to control computers, play games, and type using only their thoughts. Elon Musk has highlighted the potential of Neuralink to restore full body mobility by transferring signals from the motor cortex past spinal injuries, a feat already demonstrated in animals. The advancements in this field are generating significant interest among investors and researchers, as they explore the implications for technology and medicine, particularly in enhancing human capabilities and treating conditions like paralysis.
View original story
Medical rehabilitation • 25%
Gaming • 25%
Communication • 25%
Other • 25%
Assistive technology for paralysis • 25%
Cognitive enhancement • 25%
Medical treatment for neurological disorders • 25%
Other • 25%
Gaming and digital device control • 25%
Medical applications • 25%
Research and development • 25%
Other • 25%
Medical (e.g., helping paralyzed individuals) • 25%
Gaming • 25%
Communication • 25%
Other • 25%
Achieves full sensory feedback • 25%
Enables multi-device control • 25%
Significant AI integration • 25%
Other • 25%
Full success • 25%
Partial success • 25%
No success • 25%
Trial discontinued • 25%
Communication enhancement for ALS patients • 25%
Cognitive enhancement for general users • 25%
Control of tech devices like Apple Vision Pro • 25%
Medical research and trials • 25%
Very Positive • 25%
Somewhat Positive • 25%
Neutral • 25%
Negative • 25%
Yes • 50%
No • 50%
United States • 25%
European Union • 25%
Asia • 25%
Other • 25%
New regulatory approval • 25%
New patient milestone • 25%
Commercial availability plans • 25%
New technological breakthrough • 25%
No • 50%
Yes • 50%
Other • 25%
Improvement in speech • 25%
Restoration of hand movement • 25%
Restoration of leg movement • 25%